Immune reconstitution disease associated with parasitic infections following antiretroviral treatment (Q36624200)

15 August 2017

1 reference

25 October 2022

Immune reconstitution disease associated with parasitic infections following antiretroviral treatment (English)

1 reference

human immunodeficiency virus infectious disease

15 August 2017

1 reference

parasitic infectious diseases

13 November 2020

1 reference

13 November 2020

1 reference

13 November 2020

highly active antiretroviral therapy

1 reference

26 January 2021

2

1 reference

15 August 2017

S D Lawn

1

1 reference

15 August 2017

1 November 2006

10 references

15 August 2017

23 March 2019

25 June 2019

19 October 2019

18 October 2019

1 July 2020

13 November 2020

22 January 2021

26 January 2021

25 October 2022

10 references

15 August 2017

23 March 2019

25 June 2019

19 October 2019

18 October 2019

1 July 2020

13 November 2020

22 January 2021

26 January 2021

25 October 2022

28

1 reference

15 August 2017

625-633

1 reference

15 August 2017

11

1 reference

Creative Commons Attribution 2.5 Generic

15 August 2017

1 reference

CD4 cell count recovery among HIV-infected patients with very advanced immunodeficiency commencing antiretroviral treatment in sub-Saharan Africa

25 October 2022

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1636681

Tegumentary leishmaniasis as a manifestation of immune reconstitution inflammatory syndrome in 2 patients with AIDS.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1636681

Persistence of HIV-1 structural proteins and glycoproteins in lymph nodes of patients under highly active antiretroviral therapy

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1636681

Parasite immune escape: new views into host-parasite interactions

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1636681

Immune reconstitution disease associated with mycobacterial infections in HIV-infected individuals receiving antiretrovirals

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1636681

The prevalence and risk of immune restoration disease in HIV-infected patients treated with highly active antiretroviral therapy.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1636681

Immune restoration disease after antiretroviral therapy

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1636681

B lymphocyte dysfunctions in HIV infection

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1636681

The impact of highly active antiretroviral therapy (HAART) on visceral leishmaniasis in Spanish patients who are co-infected with HIV.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1636681

The pathogenesis of Leishmania/HIV co-infection: cellular and immunological mechanisms

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1636681

The immune reconstitution inflammatory syndrome

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1636681

Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1636681

Reconstitution of CD4+ T lymphocytes in HIV-infected individuals following antiretroviral therapy

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1636681

Immune restoration and CD4+ T-cell function with antiretroviral therapies

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1636681

CD4(+) cells are indispensable for ulcer development in murine cutaneous leishmaniasis

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1636681

Post-kala-azar dermal leishmaniasis during highly active antiretroviral therapy in an AIDS patient infected with Leishmania infantum

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1636681

Changing patterns of mortality across Europe in patients infected with HIV-1. EuroSIDA Study Group.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1636681

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1636681

Monocyte function in the acquired immune deficiency syndrome. Defective chemotaxis

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1636681

Missing infections in AIDS.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1636681

Human immunodeficiency virus causes mononuclear phagocyte dysfunction

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1636681

Response to immunization with recall and neoantigens after prolonged administration of an HIV-1 protease inhibitor-containing regimen. ACTG 375 team. AIDS Clinical Trials Group.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1636681

Paradoxical worsening of tuberculosis following antiretroviral therapy in patients with AIDS.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1636681

Role of CD4+ T cells in pathogenesis associated with Leishmania amazonensis infection.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1636681

Rolling out antiretrovirals in Africa: there are still challenges ahead.

28 June 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2006.00900.X

Highly active antiretroviral therapy results in a decrease in CD8+ T cell activation and preferential reconstitution of the peripheral CD4+ T cell population with memory rather than naive cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2006.00900.X

Predictors of long-term increase in CD4(+) cell counts in human immunodeficiency virus-infected patients receiving a protease inhibitor-containing antiretroviral regimen

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2006.00900.X

Evidence of immune reconstitution in antiretroviral drug-experienced patients with advanced HIV disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2006.00900.X

Molecular correlates in AIDS patients following antiretroviral therapy: diversified T-cell receptor repertoires and in vivo control of cytomegalovirus replication.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2006.00900.X

Increased Mycobacterium tuberculosis growth in HIV-1-infected human macrophages: role of tumour necrosis factor-alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2006.00900.X

Influence of plasma viremia on defects in number and immunophenotype of blood dendritic cell subsets in human immunodeficiency virus 1-infected individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2006.00900.X

Sustained impairment of IFN-gamma secretion in suppressed HIV-infected patients despite mature NK cell recovery: evidence for a defective reconstitution of innate immunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2006.00900.X

Residual HIV-specific CD4 and CD8 T cell frequencies after prolonged antiretroviral therapy reflect pretreatment plasma virus load

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2006.00900.X

Defective dendritic cell function in HIV-infected patients receiving effective highly active antiretroviral therapy: neutralization of IL-10 production and depletion of CD4+CD25+ T cells restore high levels of HIV-specific CD4+ T cell responses indu

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2006.00900.X

The prevalence of regulatory T cells in lymphoid tissue is correlated with viral load in HIV-infected patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2006.00900.X

Epidemiologic changes in bacteremic pneumococcal disease in patients with human immunodeficiency virus in the era of highly active antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2006.00900.X

Effect of potent antiretroviral therapy on immune responses to Mycobacterium avium in human immunodeficiency virus-infected subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2006.00900.X

Association between immune recovery uveitis and a diverse intraocular cytomegalovirus-specific cytotoxic T cell response

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2006.00900.X

Inflammatory reactions in progressive multifocal leukoencephalopathy after highly active antiretroviral therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2006.00900.X

Influence of highly active antiretroviral therapy on the outcome of subclinical visceral leishmaniasis in human immunodeficiency virus-infected patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2006.00900.X

Uveitis due to Leishmania major as part of HAART-induced immune restitution syndrome in a patient with AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2006.00900.X

Strongyloidiasis in an HIV-1-infected patient after highly active antiretroviral therapy-induced immune restoration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2006.00900.X

Immune reconstitution eosinophilia due to schistosomiasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2006.00900.X

Cryptococcocal immune reconstitution disease: a major cause of early mortality in a South African antiretroviral programme

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1636681

Efficacy and immunologic responses to influenza vaccine in HIV-1-infected patients

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1636681

Immunorestitution diseases in patients not infected with HIV.

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1636681

Post-kala-azar dermal leishmaniasis manifesting after initiation of highly active anti-retroviral therapy in a patient with human immunodeficiency virus infection

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1636681

High incidence of herpes zoster in patients with AIDS soon after therapy with protease inhibitors.

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1636681

Rapidly evolving hepatitis C virus-related cirrhosis in a human immunodeficiency virus-infected patient receiving triple antiretroviral therapy

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1636681

Zidovudine-induced restoration of cell-mediated immunity to mycobacteria in immunodeficient HIV-infected patients

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1636681

Hypercalcemia: A Manifestation of Immune Reconstitution Complicating Tuberculosis in an HIV‐Infected Person

20 September 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2006.00900.X

Why Does HIV Infection Not Lead to Disseminated Strongyloidiasis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2006.00900.X

Explosion of tuberculin-specific Th1-responses induces immune restoration syndrome in tuberculosis and HIV co-infected patients

21 January 2018

1 reference

12 December 2020

Natural killer cell enumeration and function in HIV-infected and high-risk uninfected adolescents

1 reference

12 December 2020

Case report. Toxoplasma encephalitis after initiation of HAART

1 reference

12 December 2020

Paradoxical responses in a cohort of HIV-1-infected patients with mycobacterial disease

1 reference

12 December 2020

Persistent decreases in blood plasmacytoid dendritic cell number and function despite effective highly active antiretroviral therapy and increased blood myeloid dendritic cells in HIV-infected individuals

1 reference

12 December 2020

Normalization of natural killer cell function and phenotype with effective anti-HIV therapy and the role of IL-10

1 reference

12 December 2020

Safe Interruption of Maintenance Therapy against Previous Infection with Four Common HIV-Associated Opportunistic Pathogens during Potent Antiretroviral Therapy

1 reference

12 December 2020

Baseline predictors of CD4 T-lymphocyte recovery with combination antiretroviral therapy

1 reference

12 December 2020

Polymorphisms in cytokine genes define subpopulations of HIV-1 patients who experienced immune restoration diseases

1 reference

12 December 2020

Immune reconstitution cryptococcosis after initiation of successful highly active antiretroviral therapy

1 reference

12 December 2020

Reconstitution of CD4+ T cell responses in HIV-1 infected individuals initiating highly active antiretroviral therapy (HAART) is associated with renewed interleukin-2 production and responsiveness

1 reference

12 December 2020

Daily Low-Dose Subcutaneous Interleukin-2 Added To Single- or Dual-Nucleoside Therapy in HIV Infection Does Not Protect Against CD4+ T-Cell Decline or Improve Other Indices of Immune Function: Results of a Randomized Controlled Clinical Trial (ACTG 2

1 reference

12 December 2020

Two case reports of symptomatic visceral leishmaniasis in AIDS patients concomitant with immune reconstitution due to antiretroviral therapy

1 reference

12 December 2020

Fulminant ocular leishmaniasis in an HIV-1-positive patient

1 reference

12 December 2020

Assessment of Type 1 and Type 2 Cytokines in HIV Type 1-Infected Individuals: Impact of Highly Active Antiretroviral Therapy

1 reference

12 December 2020

Patterns of CD8 T cell clonal dominance in response to change in antiretroviral therapy in HIV-infected children

1 reference

12 December 2020

Strongyloides stercoralis infection as a manifestation of immune restoration syndrome

1 reference

12 December 2020

Determinants of the immune response in visceral leishmaniasis: evidence for predominance of endogenous interleukin 4 over interferon-gamma production

1 reference

12 December 2020

Restoration of IFN-gamma production and lymphocyte proliferation in visceral leishmaniasis

1 reference

12 December 2020

HIV infection of monocyte-derived macrophages in vitro reduces phagocytosis of Candida albicans

1 reference

12 December 2020

HIV infection suppresses type 1 lymphokine and IL-12 responses to Toxoplasma gondii but fails to inhibit the synthesis of other parasite-induced monokines

1 reference

12 December 2020

Positive effects of combined antiretroviral therapy on CD4+ T cell homeostasis and function in advanced HIV disease

1 reference

12 December 2020

Perturbation of CD4+ and CD8+ T-cell repertoires during progression to AIDS and regulation of the CD4+ repertoire during antiviral therapy

1 reference

12 December 2020

Leishmaniosis--new perspectives on an underappreciated opportunistic infection

1 reference

12 December 2020

Immunopathology as a result of highly active antiretroviral therapy in HIV-1-infected patients

1 reference

12 December 2020

Visceral leishmaniasis in HIV-infected patients with non-detectable HIV-1 viral load after highly active antiretroviral therapy

1 reference

12 December 2020

Determinants of paradoxical CD4 cell reconstitution after protease inhibitor-containing antiretroviral regimen

1 reference

12 December 2020

Reduction in T cell apoptosis in patients with HIV disease following antiretroviral therapy

1 reference

12 December 2020

HAART in HIV-infected patients: restoration of antigen-specific CD4 T-cell responses in vitro is correlated with CD4 memory T-cell reconstitution, whereas improvement in delayed type hypersensitivity is related to a decrease in viraemia

1 reference

12 December 2020

Dendritic cell numbers in the blood of HIV-1 infected patients before and after changes in antiretroviral therapy

1 reference

12 December 2020

Response to hepatitis A vaccine in HIV patients in the HAART era

1 reference

12 December 2020

Early mortality among adults accessing a community-based antiretroviral service in South Africa: implications for programme design

1 reference

12 December 2020

Symptomatic Schistosoma mansoni infection as an immune restoration phenomenon in a patient receiving antiretroviral therapy

1 reference

12 December 2020

10.1111/J.1365-3024.2006.00900.X

Identifiers

DOI

1 reference

release_353xphrlg5bb5bf54dks46zgwu

15 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/353xphrlg5bb5bf54dks46zgwu

24 November 2022

mapped directly with Wikidata item

PMCID

1636681

1 reference

15 August 2017

1 reference

PMCID

1636681